B6.Cg-Tg(Afp-lacZ)1Scnch/Orl

Status

Available to order

EMMA IDEM:04533
Citation informationRRID:IMSR_EM:04533 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Tg(Afp-lacZ)1Scnch/Orl
Alternative nameAFP/ßGal
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Afp-lacZ)1Scnch
Gene/Transgene symbolTg(Afp-lacZ)1Scnch

Information from provider

ProviderSophie Conchon
Provider affiliationBiothérapies hépatiques, INSERM U948
Genetic informationA transgenic construct containing a gene encoding ß-galactosidase under the control of the rat alpha-fetoprotein promoter, was injected into B6D2 donor eggs. Founder lines were subsequently established and bred to C57BL/6 mice.
Phenotypic informationMice homozygous for the transgenic insert are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. These transgenic mice express ß-galactosidase (ßGal) under the control of the alpha-fetoprotein promoter. ßGal expression is detected in fetal hepatocytes and is repressed shortly after birth. This mutant mouse strain may be useful in developmental studies as well as in studies on immunity against self-antigen.
Breeding historyBackcrossed on C57BL/6 mice (8-10 generations). Strain currently inbred.
References
  • A transgenic mouse with beta-Galactosidase as a fetal liver self-antigen for immunotherapy studies.;Cany Jeannette, Avril Audrey, Pichard Virginie, Aubert Dominique, Ferry Nicolas, Conchon Sophie, ;2007;Journal of hepatology;47;396-403; 17462783
  • DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination.;McIlroy Dorian, Barteau Benoît, Cany Jeannette, Richard Peggy, Gourden Clothilde, Conchon Sophie, Pitard Bruno, ;2009;Molecular therapy : the journal of the American Society of Gene Therapy;17;1473-81; 19417740
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivingheterozygous males, wild-type C57BL/6J females

Literature references

  • A transgenic mouse with beta-Galactosidase as a fetal liver self-antigen for immunotherapy studies.;Cany Jeannette, Avril Audrey, Pichard Virginie, Aubert Dominique, Ferry Nicolas, Conchon Sophie, ;2007;Journal of hepatology;47;396-403; 17462783
  • DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination.;McIlroy Dorian, Barteau Benoît, Cany Jeannette, Richard Peggy, Gourden Clothilde, Conchon Sophie, Pitard Bruno, ;2009;Molecular therapy : the journal of the American Society of Gene Therapy;17;1473-81; 19417740

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).